ZBH - Zimmer Biomet Holdings, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
6,939,900
6,939,900
6,827,300
7,024,500
7,982,200
Cost of revenue
2,019,500
2,019,500
1,960,400
2,128,300
2,252,600
Gross profit
4,920,400
4,920,400
4,866,900
4,896,200
5,729,600
Operating expenses
Research development
406,000
406,000
435,800
372,000
449,300
Selling general and administrative
2,761,700
2,761,700
2,843,400
3,177,800
3,343,800
Total operating expenses
3,728,300
3,728,300
3,861,500
4,198,300
4,459,800
Operating income or loss
1,192,100
1,192,100
1,005,400
697,900
1,269,800
Interest expense
164,800
164,800
208,400
212,000
226,900
Total other income/expenses net
-623,800
-623,800
-298,000
-760,300
-137,100
Income before tax
403,500
403,500
499,000
-274,400
905,800
Income tax expense
112,300
112,300
53,500
-137,000
-225,700
Income from continuing operations
291,200
291,200
445,500
-137,400
1,131,500
Net income
231,400
231,400
401,600
-138,900
1,131,600
Net income available to common shareholders
231,400
231,400
401,600
-138,900
1,131,600
Basic EPS
-
1.10
1.93
-0.67
5.52
Diluted EPS
-
1.10
1.91
-0.67
5.47
Basic average shares
-
209,600
208,600
207,000
205,100
Diluted average shares
-
210,300
210,400
207,000
206,700
EBITDA
-
1,494,700
1,645,100
970,300
2,138,800